DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)

DongKoo Bio & Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	142,782	147,920	131,049	156,349	169,609	232,556
Market Cap Growth	5.81%	12.87%	-16.18%	-7.82%	-27.07%	-3.33%
Enterprise Value	236,856	232,426	172,921	172,036	175,056	221,869
Last Close Price	5280.00	5470.00	4694.12	5398.48	5731.92	7541.16
PE Ratio	2.95	2.94	64.38	13.24	25.64	24.94
PS Ratio	0.59	0.61	0.53	0.73	0.87	1.50
PB Ratio	0.94	0.97	1.24	1.42	1.66	2.32
P/TBV Ratio	0.98	1.01	1.31	1.57	1.82	2.40
P/FCF Ratio	-	-	-	-	14.32	17.05
P/OCF Ratio	-	-	7.56	43.61	10.08	12.99
EV/Sales Ratio	0.98	0.96	0.69	0.80	0.90	1.43
EV/EBITDA Ratio	13.04	12.79	8.66	8.33	7.79	16.82
EV/EBIT Ratio	25.61	25.13	13.63	11.77	10.40	27.26
EV/FCF Ratio	-10.79	-	-	-	14.78	16.27
Debt / Equity Ratio	0.85	0.85	0.82	0.40	0.34	0.24
Debt / EBITDA Ratio	7.09	7.09	4.34	2.12	1.53	1.84
Debt / FCF Ratio	-	-	-	-	2.90	1.78
Net Debt / Equity Ratio	0.62	0.62	0.48	0.19	-0.01	-0.08
Net Debt / EBITDA Ratio	5.15	5.15	2.52	1.01	-0.04	-0.59
Net Debt / FCF Ratio	-4.27	-4.27	-11.14	-2.04	-0.07	-0.57
Asset Turnover	0.84	0.84	1.15	1.19	1.19	1.04
Inventory Turnover	2.05	2.05	2.20	2.26	2.74	2.52
Quick Ratio	0.40	0.40	0.50	0.61	0.83	0.97
Current Ratio	0.92	0.92	0.93	1.21	1.32	1.48
Return on Equity (ROE)	38.95%	38.95%	1.84%	11.11%	6.54%	9.58%
Return on Assets (ROA)	1.99%	1.99%	3.65%	5.03%	6.44%	3.40%
Return on Invested Capital (ROIC)	3.43%	3.76%	4.61%	10.07%	14.53%	7.40%
Return on Capital Employed (ROCE)	4.60%	4.60%	9.90%	12.40%	15.90%	7.80%
Earnings Yield	35.21%	33.99%	1.55%	7.56%	3.90%	4.01%
FCF Yield	-15.37%	-14.84%	-3.45%	-6.56%	6.98%	5.86%
Payout Ratio	6.45%	6.46%	162.74%	25.72%	42.39%	10.11%
Buyback Yield / Dilution	-3.42%	-3.42%	1.74%	0.48%	1.78%	0.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.